Lp‐PLA2 levels in HIV‐infected patients

Beatriz Díaz‐Pollán(Hospital Universitario La Paz), Jesús San Román‐Montero(Universidad Rey Juan Carlos), Dulcenombre Gómez‐Garré(Universidad Complutense de Madrid), Vicente Estrada(Instituto de Salud Carlos III), Manuel Fuentes(Hospital Clínico San Carlos)
Journal of the International AIDS Society
November 1, 2014
10.7448/ias.17.4.19721
Cited by 6

Related Papers

Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy
|JAMA|2016|1.4k
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study
|The Lancet|2019|1k
Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19
|JAMA|2021|728
The KLEAN study of fosamprenavir-ritonavir versus lopinavir-ritonavir, each in combination with abacavir-lamivudine, for initial treatment of HIV infection over 48 weeks: a randomised non-inferiority trial
|The Lancet|2006|343
Altered metabolism of gut microbiota contributes to chronic immune activation in HIV-infected individuals
|Mucosal Immunology|2014|332